Because GLP-1 medicines slow digestion, they may affect the absorption rate of other oral drugs
The LEADER trial (liraglutide) and SUSTAIN-6 trial (semaglutide) demonstrated cardiovascular risk reduction over multi-year follow-up periods (approximately 3.8 years and 2.1 years, respectively)
Bowel obstruction: Blockage in the intestines requiring immediate medical intervention
Why patients choose R+H Aesthetic Medicine for post-weight-loss tightening Patients who are navigating GLP-1 changes often share one fear: I do not want to gamble with my face. R+H Aesthetic Medicine is an award-winning, MD owned medical practice with deep injection and device expertise, built around safety, comfort, results, and luxury
These medications should be avoided during pregnancy and breastfeeding
This is why patients who are evaluated at Princeton Sports and Family Medicine, P.C